The effects of venlafaxine on cognitive fuctions and quantitative EEG in healthy volunteers

Pharmacopsychiatry

Volumn 41, Issue 4, 2008, Pages 146-150

  Siepmann, T ^a   Mueck Weymann, M ^b   Oertel, R ^a   Kirch, W ^a   Pittrow, D ^a   Siepmann, Martin ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESVENLAFAXINE; PLACEBO; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; MORNING DOSAGE; MOTOR COORDINATION; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SHORT TERM MEMORY;

ADULT; ANALYSIS OF VARIANCE; BRAIN; COGNITION; CROSS-OVER STUDIES; CYCLOHEXANOLS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EYE MOVEMENTS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 49249110370     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076724     Document Type: Article

References (40)

1. Altmann HJ, Normile HJ, Galloway MP, Ramirez A, Azmitia EC. Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentiation of the hippocampus. Brain Res 1990; 581: 61-66
2. Baud P, Roch K Le, Sebban C. Quantified EEG and psychometric effects of 3 doses of dexfenfluramine in the young adult. Neurophysiol Clin 1989; 19: 241-255
3. Carey GJ, Costall B, Domeney AM, Gerrard PA, Jones DN, Naylor RJ et al. Ondasetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset Pharmacol Biochem Behav 1992; 42: 75-83
4. Carli M, Samanin R. The 5-HT(1A) receptoragonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychopharmacology 2000: 149: 259-268
5. Hindmarch I. Instrumental assessment of psychomotor functions and the effects of psychotropic drugs. Acta Psychiatr Scand 1994; 89 (Suppl 380): 49-52
6. Hindmarch I. Relevant psychometric tests for antidepressants and anxiolytics. Int Clin Psychopharmacol 1994; 9 (Suppl 1): 27-33
7. Hindmarch I, Harrison C. The effects of paroxetine and other antidepressants in combination with alcohol on psychomotor activity related to car driving. Hum Psychopharmacology 1988; 3: 13-20
8. Hindmarch I, Rigney U, Stanley N, Briley M. Pharmacodynamics of milnacipran in young and elderly volunteers. Br J Clin Pharmacol 2000; 49: 118-125
9. Hunter AM, Leuchter AF, Morgan M, Cook IA, Abrams M, Siegmann B et al. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology 2005; 30: 792-799
10. Kerr JS, Powell J, Hindmarch I. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 1996; 42: 239-241
11. Lader M, Melhuish A, Frcka G, Fredricson Overo K, Christensen V. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 1986; 31: 183-190
12. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002; 159: 122-129
13. Lucki I. The spectrum of behaviours influenced by serotonin. Biol Psychiatr 1998; 44: 151-162
14. Makela P, Wakeley J, Gijsman H, Robson PJ, Bhagwagar Z, Rogers RD. Low doses of Δ-terahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults. Neuropsychopharmacology 2006: 31: 462-470
15. Möller HJ, Langer S, Schmauss M. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany. Pharmacopsychiatry 2007; 40: 53-57
16. Moser L, Hüther KJ, Koch-Weser J, Lundt PV. Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings. Eur J Clin Pharmacol 1978; 14: 417-423
17. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB. Antidepressant biochemical profile of the novel bicyclic compound Wy45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35:4493-4497
18. Nathan PJ, Sitaram G, Stough C, Silberstein RB, Sali A. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behav Pharmacol 2000; 11: 639-642
19. O'Hanion JF, Robbe HW, Vermeeren A, Leeuwen C van, Danjou PE. Venlafaxine's effects on healthy volunteer's driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 1998; 18: 212-221
20. Patat A, Troy S, Burke J, Trocherie S, Danjou P, Le Coz F et al. Absolute bioavailability and electroencephalographic effects of conventional and extended-release formulations of venlafaxine in healthy subjects. J Clin Pharmacol 1998: 38: 256-267
21. Quartermaine D, Ciemente J, Shemer A. 5-HT1A agonists disrupt memory of fear conditioning in rats. Biol Psychiat 1993; 33: 247-254
22. Ramaekers JG, Muntjeweroff ND, O'Hanion JF. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Psychopharmacol 1995; 39: 397-404
23. Reid MS, Flammino F, Howard B, Nilsen D, Prichep, LS. Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans. Neuropsychopharmacology 2006; 31: 872-884
24. Riedel WJ, Eikmans K, Heldens A, Schmitt JA. Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J Psychopharmacol 2005; 19: 12-20
25. Robbins TW. Arousal systems and attentional processes. Biol Psychol 1997:45:57-71
26. Roseboom PH, Kalin NH. Neuropharmacology of venlafaxine. Depression and Anxiety 2000; 12 (Suppl 1): 20-29
27. Saletu B, Anderer P, Soletu-Zyhlarz GM. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmaco-dynamics of psychotropic drugs. Clin EEG Neurosci 2006: 37: 66-80
28. Saletu B, Grünberger J, Anderer P, Linzmayer L, Semlitsch HV, Magni G. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology. Br J Clin Pharmacol 1992: 33: 589-601
29. Schmitt JA, Ramaekers JG, Kruizinga MJ, Botel MP van, Vuurman EF, Riedel WJ. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. J Psychopharmacol 2002; 16: 207-214
30. Siepmann M, Grossmann J, Mück-Wemyann M, Kirch W. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology 2003; 168: 293-298
31. Siepmann M, Handel J, Mück-Weymann M, Kirch W. The effects of moclobemide on autonomic and cognitive functions in healthy volunteers. Pharmacopsychiatry 2004; 37: 81-87
32. Siepmann M, Krause S, Joraschky P, Mueck-Weymann M, Kirch W. The effects of St. John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. Br J Clin Pharmacol 2002; 54: 277-282
33. Siepmann T, Ziemssen T, Mueck-Weymann M, Kirch W, Siepmann M. The effects of venlafaxine on autonomic functions in healthy volunteers. J Clin Psychopharmacol 2007; 27: 687-691
34. Smirni P, Villardita C, Tappala G. Influence of different paths on spatial memory performance in the block-tapping test. Clin Neuropsychol 1983; 5: 355-359
35. Versavel M, Leonard JP, Herrmann WM. Standard operating procedure (SOP) for the registration and computer-supported evaluation of pharmaco-EEG data.Working team"EEG in phase I" of CIPS. Pharmaco-psychiatry 1995; 28: 245-248
36. Wakeno M, Okugawa G, Takekita Y, Kato M, Fukuda T, Yamashita M et al. Delirium associated with paroxetine in an elderly depressive patient: a case report. Pharmacopsychiatry 2007; 40: 199-200
37. Weinstein A, Wilson S, Bailey J, Nutt D. Sedative antidepressants impair visual detection mechanisms in humans. J Psychopharmacol 1996; 10: 141-145
38. Wesnes K, Simpson PM, Jansson B, Grahnén A, Weimann HJ, Küppers H. Moxonidine and cognitive function: interactions with moclobemide and lorazepam. Eur J Clin Pharmacol 1997; 52: 351-358
39. Winter JC, Petti DT. The effects of 8-hydroxy2-(di-n-propylamino)-tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory. Pharmacol Biochem Behav 1987; 27: 625-628
40. Yasuno F, Suhara T, Nakayama T, Ichimiya T, Okubo Y, Takano A et al. Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. Am J Psychiatry 2003; 160: 334-340